Andrew Gwynne MP: speeches 2025

355 published records · newest first.

Speeches

  • 7 Jan 2025 · Tobacco and Vapes Bill (Second sitting) · Hansard source
    More

    Q Professor Daszkiewicz—I hope I have pronounced that right—we heard earlier from the chief medical officer of Wales and from representatives of Action on Smoking and Health Wales about the extension of outdoor smoke-free spaces in Wales. What can we learn from the experiences of Wales in extending to schools, hospitals and children’s playgrounds? Professor Tracy Daszkiewicz: It is a really useful question. It is about looking at it through multiple lenses. So there is the enforcement element of it, but there are also the elements that go behind that. If you take hospitals as an example in terms of having NHS smoke-free sites, enforcement is part of that, but it is also about having cessation services in place. If you have people going in for elective surgery, for example, you have got a period of time where you can put in a smoking cessation intervention. It is a “waiting well” method, if you like, so that people go in for surgery in a way that makes for the best possible outcomes, and have an opportunity to either get towards a quit or at least not go in smoking. That enables patients not to be going outside and using cigarettes and so on, which enables that smoke-free site and also creates better outcomes for our patients. So, we do need to think about that. There has to be a common-sense approach. We know that vaping is a tool towards quitting smoking; we recognise that is part of the process. Where we can get people off tobacco smoking, that is crucial, particularly around health and wellbeing. The open spaces element and the public spaces element is a part that we have really focused on in Wales. The learning from that is still going on; it is not the end of the road. We are learning all the time, adapting to new evidence and making the changes that we need to make to enforce that more consistently, but in a fair way for our population.

  • 7 Jan 2025 · Tobacco and Vapes Bill (Second sitting) · Hansard source
    More

    Q In terms of other measures in the Bill, advertising and sponsorship is one side of it, but another aspect will be bringing in regulations on flavours and packaging, subject to the Bill receiving Royal Assent. Do you think that will have an impact on youth vaping? Matthew Shanks: Packaging and flavouring is really important. As I said before, it is set out as if it were sweets and bubblegum. Why would you need these different flavours? Why are they making something more attractive that is meant to help you stop doing something, so that if you do not like one flavour, you can try lots of them, and collect the different coloured vapes, or build them up into towers? Addressing all those things would help. Linking vaping with smoking, in terms of not being able to purchase it as you go up the age range, would also help. Vape-free zones are really important. People are vaping indoors. I have seen it today in London on the tube, in pubs and other places—I have not been in a pub today, by the way; that was over the Christmas period, but people are vaping in pubs in the way they used to with cigarette smoke. Again, it is not seen as something dangerous. If you put all that out there and then put children into the mix and they are looking up and seeing the colourful packaging, the flavouring and so on, why would they not do this?

  • 7 Jan 2025 · Tobacco and Vapes Bill (Second sitting) · Hansard source
    More

    Q Welcome to the Committee, and I thank you both for your time. In answer to the shadow Minister, you have outlined some of the early impacts of vaping that we are seeing in patients. But I am interested in smoking—tobacco is a killer. Following on from the evidence this morning from the CMOs from across the UK, what impacts of smoking do you see in your patients—I include second-hand smoking in that analysis—and what difference do you think the measures in the Bill will make? Professor Steve Turner: Smoking is bad whether you are an active smoker or a passive smoker. Sadly, there are lots of children who still actively smoke, but there are many hundreds of thousands of children who are exposed to second-hand smoke in the home. There is undeniable evidence that that exposure is harmful. I do respiratory paediatrics. Asthma admissions are very common and are clearly associated with exposures. We can look at natural experiments. For example, in Scotland we had the “Take it right outside” campaign, which was a smoke-free homes initiative. After that, there was a reduction in the number of children coming into hospital. When we brought in the ban on smoking in cars in Scotland, there was another reduction. On that whole-population basis, there is a lot of evidence of benefit to the population, particularly children, from smoking interventions. There are also benefits to the birth weight of children. There is no doubt that there is a huge amount of harm from second-hand smoke, and anything that reduces the population’s exposure to second-hand smoke will benefit the whole population. As we heard earlier from Matthew, the headteacher, it is part of a package, and it is part of education as well. Smoking continues to be something that children should not do. Children should never vape. Children should never smoke. They continue to do so, and anything that we as a responsible society can do to stop that is to everybody’s benefit.

  • 7 Jan 2025 · Tobacco and Vapes Bill (Second sitting) · Hansard source
    More

    Q On proof of age and identification, which do you think is more complex? Is it having to work out, on a daily basis, whether somebody is over the age of 18 from their date of birth, or is it just being able to see that they were born after 1 January 2009? Inga Becker-Hansen: Currently, retailers are used to the idea of over the age of 18, simply because of tobacco and alcohol sales. The identification of January 2009 is more difficult, in terms of the rolling age and how that will look in the future. Currently, it is quite identifiable. I would say that January 2009 is more difficult for retailers to handle in the future per se.

  • 7 Jan 2025 · Tobacco and Vapes Bill (Second sitting) · Hansard source
    More

    Q One of the issues that came up on Second Reading and in the previous iteration of this Bill is that some people question whether moving to a smoke-free generation policy risks a growth in the black market and illicit trade. Does that accord with your experience of the illicit tobacco market and previous tobacco control measures? Lord Michael Bichard: No. Our experience of the illicit tobacco market is that it has reduced rather than increased, despite the additional regulation, the price rise and all the rest of it, so we do not think that is a serious issue. We think that there are a number of myths around illicit tobacco and illicit vapes that do not stand up to close scrutiny. So no, we do not think that is a serious problem.

  • 7 Jan 2025 · Tobacco and Vapes Bill (Second sitting) · Hansard source
    More

    Q The Bill seeks to reduce youth vaping. How do you think we can best achieve that while not deterring adult smokers from quitting? Professor Steve Turner: That is a really good question. I think that the balance in this Bill—between supporting the 6 million smokers to quit and not engaging children in nicotine addiction—is the right balance. Going back to what I was saying earlier, getting the message across to young people is a multifaceted intervention that requires education as well as legislation. It is a really difficult balance, but I do believe that the Bill, as it is, has that balance just right.

  • 7 Jan 2025 · Tobacco and Vapes Bill (Second sitting) · Hansard source
    More

    I beg to move a manuscript amendment: That the Order of the Committee of 7 January 2023 be varied by leaving out from “Aneurin Bevan University Health Board” to end of table and insert— Tuesday 7 January Until no later than 3.10 pm Professor Linda Bauld OBE, Bruce and John Usher Chair in Public Health, University of Edinburgh Tuesday 7 January Until no later than 3.30 pm National Trading Standards Tuesday 7 January Until no later than 3.50 pm British Retail Consortium Tuesday 7 January Until no later than 4.10 pm Department for Education’s Secondary Headteacher Reference Group Tuesday 7 January Until no later than 4.30 pm Medicines and Healthcare products Regulatory Agency Tuesday 7 January Until no later than 5.00 pm Royal College of Paediatrics and Child Health; Royal College of General Practitioners Tuesday 7 January Until no later than 5.20 pm Department of Health and Social Care This amendment is in order to accommodate witness availability. It would take Professor Linda Bauld at 2.40 pm and move the witnesses representing the royal colleges to start at 4.30 pm. This will add an extra 10 minutes to the last two panels, concluding oral evidence at 5.20 pm. Manuscript amendment agreed to.

  • 7 Jan 2025 · Tobacco and Vapes Bill (Second sitting) · Hansard source
    More

    Q I thank the LGA for the support and engagement that we have had in drawing up the measures. Do you think that the Bill gives local authorities the right tools in relation smoking and vaping? How can we best work with colleagues in local government to get this right and ensure that it is workable on the ground? David Fothergill: The engagement has been really positive and constructive. We have faith in the Bill and that it has the right intention, the right measures and the right provisions. Our concern is around the funding, the timing and the pipeline of trading standards. The key thing for us is that it is an empowering Bill; it empowers local authorities. If you tried to legislate for every single local authority to implement it in the same way, we would run into some quite difficult conversations and difficult times; it would make enforcement more difficult. Allowing local councils to do what is right for them is the route to go. People who sit on licensing committees have local understanding. I can give you an example. Should we ban the sale of tobacco within 100 metres of a school? That would be quite easy to do in an urban area, but I look after villages. If you do that, they have lost their only shop. People would not be able to go to that shop to buy legally. So you have got to have local knowledge. It is the right Bill, but we need to make sure that it is an empowering Bill for local authorities to implement in their local communities.

  • 7 Jan 2025 · Tobacco and Vapes Bill (Second sitting) · Hansard source
    More

    Q I can assure you that there will be consultation with the sector. What would you want to see from a licensing scheme? Are there any lessons from supporting the implementation of alcohol licensing, for example? Inga Becker-Hansen: We would like to see a licensing scheme as a level playing field where small, independent and larger retailers are viewed on the same level. Again, we would encourage the multi-stores to require only one licence rather than looking at individual premises licences, because that will make things more difficult. In terms of the tobacco scheme, ideally things would be grouped together so that there is less administrative burden and therefore less cost for retailers, so that, if the aim for the Government is to transfer from the idea of selling tobacco to people to selling vapes because of the health benefits, that transition is made easier for retailers. Adding on an additional licensing scheme with additional costs and a separate administrative system makes it more difficult for retailers to handle those things at the same time, particularly smaller retailers and independents.

  • 7 Jan 2025 · Tobacco and Vapes Bill (Second sitting) · Hansard source
    More

    Q Of course local government has been at the forefront of enforcing existing tobacco measures. What lessons can we learn from the experience of local government in terms of enforcement to date? David Fothergill: It is very much about keeping our feet on the ground. Let us be honest: trading standards are under a lot of pressure and have been cut over the last 10 years. Trading standards have responsibility for enforcing over 300 pieces of legislation, so there is a lot of pressure on trading standards; but I think that by working with retailers and building the relationship locally and ensuring that we use enforcement as the final tool, we can work very well in our local areas.

  • 7 Jan 2025 · Tobacco and Vapes Bill (Second sitting) · Hansard source
    More

    Q The measures in the Bill include the introduction of a licensing scheme for England, for Wales and for Northern Ireland. Scotland already has its own arrangements, which the Bill will seek to extend. What would you like to see from a licensing scheme? David Fothergill: We would like to see a licensing scheme that is very aligned with the alcohol licensing scheme, although there clearly cannot be a single scheme. The four provisions within the alcohol licensing scheme brought in by the Licensing Act 2003 were preventing crime and disorder, ensuring public safety, preventing public nuisance and protecting children from harm. If we can build those provisions into this legislation for the licensing of the sale of tobacco and vapes, that will give us enough to work on. I would also say that the flexibility we need at a local level remains critical.

  • 7 Jan 2025 · Tobacco and Vapes Bill (Second sitting) · Hansard source
    More

    Q I am not sure whether you understood the question that I was asking. If I have a piece of ID that shows clearly that I was born after 1 January 2009, that is very simple to understand. If I say I was born on 4 June 1974, it is obvious that I am over 18, but if it was 2004 rather than 1974, you would have to calculate in your head what my age is. Inga Becker-Hansen: Yes, currently that is true. However, in the future, if somebody walks into a store and they are 45 or 43, I would not be able to tell that at face value.

  • 7 Jan 2025 · Tobacco and Vapes Bill (Second sitting) · Hansard source
    More

    Q Welcome to the Committee. Can you outline the lessons from the introduction of previous tobacco control policies, for example on age of sale change, which we can consider as we introduce the measures in the Bill? Inga Becker-Hansen: Retailers are quite comfortable with the licensing scheme for tobacco at this point. That is something we are used to as a whole. One aspect of it is the fact that your larger retailers, for example, who have multiple premises do not have to worry about individual licenses for those individual premises. That is something we are quite concerned about with the licensing scheme, and what that could mean. If individual licenses had to be applied for, that could lead to divergence across a retail brand, and that affects your overall public retail image for customers. We would also like to highlight that if the licensing scheme were to follow something such as the tobacco licensing scheme—the idea that licensing authorities could approve or deny certain applications—that could affect long-standing, established, compliant retailers, and that could lead to a loss of revenue for them. We appreciate the need for the legislation. We appreciate the need for a level playing field, and that is what we would encourage through the Bill.

  • 7 Jan 2025 · Topical Questions · Hansard source
    More

    My hon. Friend raises a really important point. NHS England is due to complete a stocktake of long covid services throughout England at the end of this month. That will provide an accurate in-depth overview of not only long covid services but ME/CFS—myalgic encephalomyelitis/chronic fatigue syndrome—services. The stocktake will provide a comprehensive and accurate national picture, identify key challenges and make strategic recommendations for future service improvement, development and assurance.

  • 7 Jan 2025 · Topical Questions · Hansard source
    More

    In September the Secretary of State and I met the families of people who had suffered harm following the covid-19 vaccination, including my hon. Friend’s constituent Sheila Ward, and they raised the need for reform of the vaccination damage scheme. We listened closely to their descriptions of what they had been through and agreed to look at a number of options, noting that cross-cutting Government decisions might be necessary. We are also working with the NHS Business Services Authority to improve claimants’ experiences of the scheme, and to ensure that claims are processed quickly.

  • 7 Jan 2025 · Topical Questions · Hansard source
    More

    I am very sorry to hear about the hon. Gentleman’s constituent. I know at first hand how complex and debilitating long covid can be. As I mentioned in an earlier answer, there is a stocktake taking place, which should show where there are deficiencies, but let me be clear: I want to ensure that there are good services for people suffering with long covid in every part of England.

  • 7 Jan 2025 · Tobacco and Vapes Bill (First sitting) · Hansard source
    More

    Q I turn to two criticisms of the Bill raised on Second Reading. We have already touched on some of the libertarian arguments, but I would like to know whether you think the issue of choice is addressed by the Bill. Do you have any sympathy with the libertarian argument, or do you think that the Bill—tackling tobacco and child vaping—is something that the libertarian argument does not stand up against? Professor Sir Chris Whitty: I have already given my view that, although I have a lot of sympathy for choice and freedom arguments in many situations, tobacco addiction and second-hand smoking are not among those. Sir Francis Atherton: If anything, choice is undermined by the addictive nature of nicotine. It is incredibly addictive. We know that now; we have known it for many years, actually. The tobacco industry has known it for many years, which is why the industry, through vaping and other means, is quite keen to have the next generation of people in our countries addicted to nicotine. Choice is completely undermined and taken away by the addictive nature of the product being marketed. Professor Sir Gregor Ian Smith: Nicotine addiction is horrific. Nearly 9,000 people a year still die in Scotland as a result of tobacco-related health issues. Two thirds of people who begin smoking are potentially at risk of dying as a consequence of their addiction. We know that the industry targets both the younger age spectrum and vulnerable groups to sustain their industry. If you have ever spoken to a patient with a serious tobacco-related illness such as chronic obstructive pulmonary disease, who is now suffering from the consequences of that—the limited ability to live their life—and the addictive nature of the disease, you soon begin to learn that they are filled with nothing but regret and guilt for the part that their addiction has played in the development of the disease. The stigma associated with tobacco-related disease is quite terrible for those who experience it. The basis of that is this lack of choice that they have developed as a consequence of the addictive nature of the nicotine products. Professor Sir Chris Whitty: If I could just add a specific example from—

  • 7 Jan 2025 · Tobacco and Vapes Bill (First sitting) · Hansard source
    More

    Q Ministers and officials have worked really hard, across the four nations, to put together a piece of legislation that is relevant to all four nations. How important do you think it is that the Bill extends powers and responsibilities on public health across the four nations? Professor Sir Gregor Ian Smith: Perhaps I can begin this answer; my colleagues may then want to come in. Alignment in this respect is really important, partly because of the clarity of message that exists to the public around about what is legally acceptable in relation to smoking and to vaping. Alignment across tobacco smoking and vape use is similarly important across the four nations. Public health messaging is incredibly important. Having a consistent message across our four nations helps to ensure that the message is much more clearly understood and adhered to by the public. I welcome the attempts by Ministers to ensure that alignment exists within the Bill, so that as we go forward we give protection to those who do not smoke in the way that we are planning on doing with the Bill as it proceeds. One of the most important aspects is to make sure that, although in Scotland, for instance, legislation prevents smoking within 15 metres of the likes of public places such as outside a hospital, we bring that much more closely in line with where the Welsh position is—so to the whole of the hospital grounds. Extending it to protect, as Sir Chris has said, more vulnerable places such as play parks is something I would certainly welcome in Scotland. We should do that in step across the four nations. I again emphasise that public messaging is incredibly important in making sure that we get the adherence we seek.

  • 7 Jan 2025 · Tobacco and Vapes Bill (First sitting) · Hansard source
    More

    Q Good morning, CMOs. I would like to ask about the additions to the Bill; it is of course a reincarnation, as Professor Whitty says, of an earlier Bill from the previous Government, although we have sought to go further. In your professional opinion, what impact will the additions to the Bill have in terms of public health benefits for the four nations? Professor Sir Chris Whitty: May I take one impact that extends my previous points about outdoor smoking, and then maybe pass on to Sir Gregor and Sir Frank? For outdoor smoking, the previous Bill—the very good Bill put forward by the previous Government—did not have anything that addressed the needs of current smokers. It also did not address the needs of people exposed to smoke, despite the fact that, like over 88% of the population, they are not smokers and many of them are medically vulnerable. The Bill allows the Government to take powers to prevent outdoor smoking, first with additional public consultation and then additional measures in Parliament. Ministers—you, Minister, have demonstrated this in the House of Commons—have indicated the areas where they intend to use these powers to reduce the risks of passive smoking. These are the areas of the greatest vulnerability: around hospitals, where some of the most medically vulnerable are highly concentrated; and around children’s playgrounds, where children are—I think everybody who does not have shares in cigarette companies would agree that exposing children to second-hand smoke is an unacceptable thing to do. That is one area where the Bill has gone further than the previous one. Maybe Sir Frank might want to add to that. Sir Francis Atherton: In Wales, we have had smoke-free hospitals, schools and play areas since 2021, under our earlier public health legislation, and it is completely non-controversial. There are clearly issues around implementation and enforcement, particularly around hospitals, but if you go now to schools and hospitals there is no controversy whatever. So that will not make a huge amount of difference in Wales. The one thing that will make a difference, I think, is aligning the vaping legislation with the smoking legislation. I say that because, going back to the earliest question, vape use among young people in Wales has shot up over recent years—8% of 11 to 16-year-olds regularly vape, up from 5% and a bit in 2021. It has absolutely shot up. Bringing together vaping and tobacco legislation in terms of vape-free and smoke-free places is a really important thing and one for which I have been arguing for quite some time.

  • 7 Jan 2025 · Tobacco and Vapes Bill (First sitting) · Hansard source
    More

    Q In a nutshell, how important is it that the measures in the Bill are passed? Dr Ian Walker: Critical. Without a doubt, there is no single bigger action that you could take to reduce the cancer burden on the country. The cancer burden sits at a very personal, individual level for people getting their own diagnosis; it sits at a family level and at a friend level. It also sits at an economic level for the country and at an NHS level, in terms of the burden that smoking-related illnesses cause for the NHS. From my perspective, this is a world-leading piece of legislation. It is absolutely an opportunity for generational change and a long-term legacy that will see our children and grandchildren never able to legally buy tobacco in the UK and never exposed to the harms that that would cause them.

  • 7 Jan 2025 · Tobacco and Vapes Bill (First sitting) · Hansard source
    More

    Q What impact have tobacco control measures had over time to date, and what impact do you expect this Bill to have in addition? Sheila Duffy : We have seen that tobacco control measures work. We have seen that they have reduced adult smoking rates over time. The points made by the chief medical officers were well made: we are looking to the generation growing up now in the UK; we are looking to protect them from addictions that so many now regret and that are claiming lives unnecessarily. Suzanne Cass : I would add that tobacco control policies that are put in place are popular, and are really welcomed among members of the public; they are also welcomed among people who smoke. There is a huge surge of public support for tobacco control policies, and that grows—it does not diminish—as we introduce new policies; it grows, and that public support increases. Naomi Thompson: In Northern Ireland, we are working towards a smoke-free Northern Ireland by 2035, and the reality is that tobacco control over the past 10 years has managed to bring things down to a stage where 2035 has potential. That is why tobacco control needs to continue. A Bill like this is just brilliant to keep that focus. If we can prevent people from starting, that will be absolutely key to making Northern Ireland, certainly, smoke-free by then.

  • 7 Jan 2025 · Tobacco and Vapes Bill (First sitting) · Hansard source
    More

    Q The Bill takes powers to introduce restrictions on vaping, which are obviously subject to consultation after the Bill receives Royal Assent. What factors do you think will need to be taken into consideration as part of that further consultation? Sarah Sleet: People with asthma and lung conditions are in the middle, where they are affected by both smoking and vaping. It is really important to get the balance right. Smoking is terrible—it is terrible for people with lung conditions—and we need to make sure we can drive down smoking rates as much as possible. Vaping can play a part in helping with smoking cessation, but it should only be used for smoking cessation. People who have never smoked, and definitely children, should not be taking up vaping. We see vaping as a staging post to being completely nicotine-free. It is important to get the balance right between making vaping available for those who need smoking cessation and not encouraging people to try vaping or to keep vaping longer than they need to. The legislation is good in allowing that flexibility for adjusting over time, as we get more evidence in. It is really important to put evaluation in place and make sure that robust evaluation does flow through over time, so we can adjust and respond to it. Traditionally—certainly in respiratory diseases—there has generally not been enough research and evaluation, so we need to correct that now. Dr Ian Walker: First, I want to confirm that we are very much supportive of taking those powers. I think one of the real strengths of the Bill is the ability to adjust, moderate and titrate those powers and the actions that we take over time, not just as new evidence emerges, but as the tobacco industry and new products may emerge to try to circumvent the regulation that is in place. That is a really important part of the Bill. I think the crux of the question was about what is important to consider through the consultation. From our perspective, it is important to get a balanced view on what the right actions are in this area. Of course we all agree that we want to limit, reduce and stop access for children and young people and to limit the appeal to never-smokers, while balancing that carefully against making cessation tools available to people who are trying to quit. It is important not to forget the 6 million people who are currently smokers and the long-term health implications ahead of them. We need a balance so that it is as easy as possible for those people to quit when they have chosen to do so. There will be many balancing features and balancing points of evidence that will be really important through the consultation in coming to the right outcome.

  • 7 Jan 2025 · Tobacco and Vapes Bill (First sitting) · Hansard source
    More

    Q Let me ask a question of Suzanne Cass. We heard from the CMO for Wales in the session before that the extension of smoke-free to outdoor places—such as outside hospitals, in playgrounds and outside schools—is already in place in Wales. What lessons do we need to learn from that? Suzanne Cass: As you know, ASH Wales and the Welsh Government have been at the forefront of implementing smoke-free spaces. We campaigned for smoke-free playgrounds and smoke-free school gates, both on a voluntary basis. Luckily, the foresight of the Welsh Government has made that provision legislation when it comes to hospital grounds, playgrounds, sports grounds, mental health units and a raft of other smoke- free spaces. We are obviously delighted that the Welsh Government has implemented that legislation. The legislation has made a huge difference, in that it has allowed a platform for communication—communicating the message that it is not okay to smoke around children. There is a massive amount of public support for that messaging, and we have had the opportunity to communicate it. When it comes to smoke-free hospital grounds, a lot of us are looking at that legislation and the possibility of implementing it. We have obviously had the legislation in place in Wales since 2021, and what we would say on the lessons learned is that there has to be a package when it comes to implementation. We cannot just legislate; we need to be looking at the support that is in hospitals for smokers to quit, we need to have trained staff and we need to have enforcement on the ground. There needs to be a whole package that comes with that legislation. That is the enormous lesson that we learned. We implemented that legislation in 2021—in the midst of covid, which was tricky—but we have had problems around enforcement and problems around compliance. It is a very different kind of tobacco policy from that in the other smoke-free spaces. When it comes to the other smoke-free places—playgrounds, sports grounds and other areas like that—there is a lot of compliance, but when it comes to hospital grounds, you have to do a bit more of the legwork. But it is well worth it, because what comes with that is on-site hospital support for stopping smoking, and the message to everybody coming on to that site that smoking is not okay and that there is support available if you want to quit. So it comes with a whole raft of measures that support that smoke-free message.

  • 7 Jan 2025 · Tobacco and Vapes Bill (First sitting) · Hansard source
    More

    Q Can you tell us about the evidence of the impacts of second-hand smoking on cancer in your case, Dr Walker, and on asthma and lung conditions in your case, Sarah? What difference do you think that the measures outlined in the Bill will have on those conditions? Dr Ian Walker: To start with smoking and cancer, the links between passive smoking and cancer, particularly lung cancer, are very clear. It is fair to say that there is less evidence around different scenarios that you might predict through this Bill, such as different outdoor environments and so on, but that is more because those studies have not necessarily been done. It is an important point to make that there is an absence of evidence, rather than evidence of absence. You heard from the CMO of England this morning that if you can smell cigarette smoke, you are exposed to it. The direct risk, then, is linked to how long you are exposed to it, how concentrated the environment is, how close you are to it and so on. Nevertheless, passive smoking is harmful—not just for cancer, but for vulnerable people with many other conditions as well—so we are very much supportive of the introduction of smoke-free places and the ability to restrict people smoking in particular outdoor spaces. Sarah Sleet: When it comes to people with lung conditions, second-hand smoke is incredibly important; it is a well-known, severe risk factor for people with lung conditions. About one in five of us in the UK will experience a lung condition—there are around 7 million people with asthma and about 1.6 million people living with chronic obstructive pulmonary disease. Those are two major conditions that are profoundly affected by second-hand smoking, and are clear risk factors in terms of deaths from asthma and people being hospitalised with exacerbations, so it is incredibly important that we deal with the issue of second-hand smoking. People said earlier that there is no choice about second-hand smoking, and yet it profoundly affects those with lung conditions. It is incredibly important that we ensure that we protect those vulnerable people as far as possible. When it comes to the discussion about how far we should go in terms of smoke-free and vape-free places, we would consider going further than what has been suggested already and looking at other areas to make smoke-free. I know there has been discussion about hospitality and trying to balance the potential economic impact that has been talked about if we make the outside of hospitality places smoke-free. However, we think, given the balance between the public health impact and what we have seen with smoke-free indoor spaces and its impact on business, we could go further and should go further, there.

  • 7 Jan 2025 · Tobacco and Vapes Bill (First sitting) · Hansard source
    More

    Q Good morning, all. As we know, this is a resurrected Bill from the previous Government, with additional measures. How do you think it compares with the previous iteration? Hazel Cheeseman: We are all delighted to see this Bill return, and in such a strong form. There is complete consensus across the ASHs of the four nations that this is a Bill that is needed, wanted and workable. As the chief medical officer said in the previous session, the improvements in this Bill are that there are more provisions that will assist in reducing smoking among people who are already smoking and in protecting those exposed to second-hand smoke. It also creates a comprehensive set of regulations around all tobacco and nicotine products and provides us with that future-proof—the flexibility to respond to evidence as it emerges and changes and to the market as it emerges and changes over time. The Bill is enormously welcome for its comprehensiveness and robustness, and therefore for the opportunity to significantly reduce the uptake of smoking among the next generation and to aid people in quitting. The Minister will not mind me saying that I think there is more that the Government will need to do to accelerate that progress, in terms of investing in support for those who are already smoking and ensuring that we have the right strategy in place for that, but the Bill is a really good step in the right direction.

Published records only — not a full account of an MP’s work. How we work →